In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed about the schedule of Analyst / Institutional Investor Meeting dated on Tuesday, 20th November, 2018 at 3:00 p.m.
The above information is a part of company’s filings submitted to BSE.